Oncologie

, Volume 14, Issue 6–7, pp 433–435

Un désir qui devient réalité: grossesse après chimiothérapie d’un cancer du sein

Cas Clinique / Case Report
  • 63 Downloads

Résumé

Une grossesse après chimiothérapie d’un cancer du sein n’est plus un événement rare. L’exemple de ces deux femmes ayant débuté une grossesse spontanée après chimiothérapie en est la preuve. L’information des patientes, la connaissance des médicaments et de leurs effets secondaires ainsi que les possibilités de procréation médicalement assistée permettent aux femmes qui le souhaitent d’envisager une grossesse dans des conditions de sécurité pour la mère et l’enfant.

Mots clés

Cancer du sein Chimiothérapie Grossesse Fertilité Toxicité 

A wish come true: Pregnancy after chemotherapy for breast cancer

Abstract

Pregnancy after a chemotherapy for breast cancer is no longer a rare event. The example of two women who started a spontaneous pregnancy after a chemotherapy proves it. Patient education, better knowledge of medicines and their side effects as well as the possibilities of assisted reproduction techniques now-a-days allow willing women to consider a pregnancy in secure conditions for mother and child.

Keywords

Breast cancer Chemotherapy Pregnancy Fertility Toxicity 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. 1.
    Anderson RA, Cameron D (2006) Assessment of effect of chemotherapy on ovarian function in women with breast cancer. J Clin Oncol 24: 09.3666Google Scholar
  2. 2.
    Azim HA, Jr, Santoro L, Pavlidis N, et al. (2011) Safety of pregnancy following breast cancer diagnosis: a meta-analysis of 14 studies. Eur J Cancer 47: 74–83PubMedCrossRefGoogle Scholar
  3. 3.
    Badawy A, Elnashar A, El-Ashry M, et al. (2009) Gonadotropin-releasing hormone agonists for prevention of chemotherapyinduced ovarian damage: prospective randomized study. Fertil Steril 91: 694–697PubMedCrossRefGoogle Scholar
  4. 4.
    de Bree E, Makrigiannakis A, Askoxylakis J, et al. (2010) Pregnancy after breast cancer. A comprehensive review. J Surg Oncol 101: 534–542Google Scholar
  5. 5.
    Colonna M, Delafosse P, Uhry Z, et al. (2008) Is breast cancer incidence increasing among young women? An analysis of the trend in France for the period 1983–2002. Breast 17: 289–292PubMedCrossRefGoogle Scholar
  6. 6.
    Colonna M, Delafosse P, Uhry Z et al. (2008) Is breast cancer incidence increasing among young women? An analysis for the trend in France for the period 1983–2002. BreastGoogle Scholar
  7. 7.
    Dalberg K, Eriksson J, Holmberg L (2006) Birth outcome in women with previously treated breast cancer: a populationbased cohort study from Sweden. PLoS Med 3: e336PubMedCrossRefGoogle Scholar
  8. 8.
    Del Mastro L, Boni L, Michelotti A, et al. (2011) Effect of the gonadotropinreleasing hormone analogue triptorelin on the occurrence of chemotherapyinduced early menopause in premenopausal women with breast cancer: a randomized trial. JAMA 306: 269–276PubMedCrossRefGoogle Scholar
  9. 9.
    Gerber B, von Minckwitz G, Stehle H, et al. (2011) Effect of luteinizing hormonereleasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study. J Clin Oncol 29: 2334–2341PubMedCrossRefGoogle Scholar
  10. 10.
    Grynberg M, Hesters L, Benard J, et al. (2011) In vitro maturation of oocytes: an option for fertility preservation in women. J Gynecol Obstet Biol Reprod (Paris) 40: 103–108CrossRefGoogle Scholar
  11. 11.
    HCL, InVS, INCa, et al. (2010) Projections de l’incidence et de la mortalité par cancer en France en 2010. Rapport technique. Avril 2010Google Scholar
  12. 12.
    Inserm, Cépi DC, Invs, et al. (2010) Tendance évolutive des taux de mortalité cancer par cancer. Cancer du sein, dynamique d’évolution des taux de mortalité des principaux cancers en France. Rapports & synthèses. Institut national du cancer, Paris, p 46Google Scholar
  13. 13.
    Mailliez A, Decanter C, Bonneterre J (2011) Chimiothérapie adjuvante de cancer du sein et fertilité: estimation de l’impact, options de préservation et place de l’oncologue. Bull Cancer 98: 741–751PubMedGoogle Scholar
  14. 14.
    Maltaris T, Weigel M, Mueller A, et al. (2008) Cancer and fertility preservation: fertility preservation in breast cancer patients. Breast Cancer Res 10: 206PubMedCrossRefGoogle Scholar
  15. 15.
    Munster PN, Moore AP, Ismail-Khan R, et al (2012) Randomized trial using gonadotropin-releasing hormone agonist triptorel in for the preservation of ovarian function during (Neo) adjuvant chemotherapy for breast cancer. J Clin Oncol 30: 34–6890CrossRefGoogle Scholar
  16. 16.
    Oktay K, Buyuk E, Libertella N, et al. (2005) Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol 23: 4347–4353PubMedCrossRefGoogle Scholar
  17. 17.
    Partridge AH (2005) Fertility after breast cancer: questions abound. J Clin Oncol 23: 4259–4261PubMedCrossRefGoogle Scholar
  18. 18.
    Peate M, Meiser B, Friedlander M, et al. (2011) It’s now or never: fertility-related knowledge, decision-making preferences, and treatment intentions in young women with breast cancer: an Australian Fertility Decision Aid Collaborative Group Study. J Clin Oncol 29: 1670–1677PubMedCrossRefGoogle Scholar
  19. 19.
    Rosendahl M, Ahlgren J, Andersen J, et al. (2009) The risk of amenorrhoea after adjuvant chemotherapy for early stage breast cancer is related to interindividual variations in chemotherapy induced leukocyte nadir in young patients: data from the randomised SBG 2000-1 study. Eur J Cancer 45: 3198–3204PubMedCrossRefGoogle Scholar
  20. 20.
    Sukumvanich P, Case LD, Van Zee K, et al. (2010) Incidence and time course of bleeding after long-term amenorrhea after breast cancer treatment: a prospective study. Cancer 116: 3102–3111PubMedCrossRefGoogle Scholar
  21. 21.
    Swain SA, Jeong JH, Geyer CE, et al. (2010) Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer. N Engl J Med 362: 2053–2055PubMedCrossRefGoogle Scholar

Copyright information

© Springer Verlag France 2012

Authors and Affiliations

  1. 1.Centre Alexis-VautrinVandœuvre-lès-NancyFrance

Personalised recommendations